HSK 0935)

HSK 0935) Suppliers list
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Fan De(Beijing) Biotechnology Co., Ltd.  
Tel: 15911056312
Email: liming@bio-fount.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com

HSK 0935) manufacturers

  • HSK0935
  • HSK0935 pictures
  • $2500.00
  • 2026-05-11
  • CAS:1638851-44-1
  • Purity:
  • Supply Ability: 10g
HSK 0935) Basic information
Product Name:HSK 0935)
Synonyms:HSK 0935);HSK0935 (Synonyms: HSK-0935;HSK0935 (HSK-0935;4R)-Me-Glu;β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-methoxy-;1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-methoxy-β-L-idopyranose
CAS:1638851-44-1
MF:C22H25ClO7
MW:436.89
EINECS:
Product Categories:
Mol File:1638851-44-1.mol
HSK 0935) Structure
HSK 0935) Chemical Properties
Boiling point 597.7±50.0 °C(Predicted)
density 1.43±0.1 g/cm3(Predicted)
pka12.54±0.70(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
HSK 0935) Usage And Synthesis
DescriptionHSK0935 is a potent and highly selective SGLT2 inhibitors (IC50 (hSGLT2) = 1.3 nM; IC50 (hSGLT1) + 1096nM). HSK0935 demonstrated excellent hSGLT2 inhibition of 1.3 nM and a high hSGLT1/hSGLT2 selectivity of 843-fold. It showed robust urinary glucose excretion in Sprague-Dawley (SD) rats and affected more urinary glucose excretion in Rhesus monkeys.
UsesHSK0935 is a potent, highly selective and orally available SGLT2 inhibitor with an IC50 of 1.3 nM. Antihyperglycemic activities[1].
in vivo

HSK0935 treatment (1, 3, and 10 mg/kg) shows robust urinary glucose excretion in Sprague Dawley (SD) rats and affects more urinary glucose excretion in Rhesus monkeys[1].

HSK0935 is well tolerated up to 300 mg/kg without any mortality or severe untoward effects in a 28-day repeat-dose toxicology study in beagle dogs[1].

IC 50SGLT2
References[1] Li Y, et al. Discovery of a Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor (HSK0935) for the Treatment of Type 2 Diabetes. J Med Chem. 2017 May 25;60(10):4173-4184. DOI:10.1021/acs.jmedchem.6b01818
HSK 0935) Preparation Products And Raw materials
Tag:HSK 0935)(1638851-44-1) Related Product Information
(2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-hydroxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol (2S,3R,4R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-5-((R)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol SOTA-009 D-Glucopyranoside, methyl 1-C-[4-chloro-3-[(4-methoxyphenyl)methyl]phenyl]-, tetraacetate (9CI) Dapagliflozin Impurity D galacto-Dapagliflozin